Literature DB >> 8078552

Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.

C Cunningham-Rundles1, K Kazbay, J Hassett, Z Zhou, L Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078552     DOI: 10.1056/NEJM199410063311405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Treatment of idiopathic CD4 T lymphocytopenia with IL-2.

Authors:  C Cunningham-Rundles; H W Murray; J P Smith
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID).

Authors:  J A Rump; A Jahreis; M Schlesier; S Stecher; H H Peter
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 4.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

5.  Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome.

Authors:  Y Levy; N Gupta; F Le Deist; C Garcia; A Fischer; J C Weill; C A Reynaud
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 6.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.